Anorexia nervosa and Raynaud's phenomenon: a case report.

OBJECTIVE To describe and discuss potential relationships between anorexia nervosa (AN) and Raynaud's phenomenon, the course and concurrent treatment of these two disorders as they appeared simultaneously, and a potential treatment modification entailed in such concurrent therapies. BACKGROUND Although Raynaud's phenomenon has been described during the course of AN, the associations and interactions between these two conditions are not clear. METHOD We report the medical workup, treatment, and outcomes in a 19-year old female patient who developed Raynaud's phenomenon following the onset of AN. RESULTS After treatment with nutritional rehabilitation, counseling, and individual and group therapy, the patient's weight, eating disorder-related behaviors, and attitudes improved significantly. Raynaud's related symptoms improved, following treatment with a calcium channel blocker and antiaggregant therapy. In conjunction with nutritional efforts to treat the patient's long-standing amenorrhea and osteopenia, the treatment team elected to also administer estrogen hormone in addition to oral calcium and vitamin D supplementation. Since oral contraceptives are to be avoided in patients with Raynaud's phenomenon who show clinical findings suggesting connective tissue disorder, the treatment team elected to treat this patient with transdermal hormone replacement therapy. CONCLUSION The co-occurrence of AN and Raynaud's phenomenon merits close and persistent follow-up by a multidisciplinary team and may lead to alterations of usual therapeutic approaches.

[1]  F. Ingegnoli,et al.  [Raynaud's phenomenon]. , 2011, Reumatismo.

[2]  J. Sibilia Treatment of systemic lupus erythematosus in 2006. , 2006, Joint, bone, spine : revue du rhumatisme.

[3]  L. Sandvik,et al.  The effects of oral and transdermal hormone replacement therapy on C-reactive protein levels and other inflammatory markers in women with high risk of thrombosis. , 2005, Maturitas.

[4]  Mimi Y. Kim,et al.  Outcomes of planned home births with certified professional midwives: large prospective study in North America , 2005, BMJ : British Medical Journal.

[5]  J. Pope,et al.  Calcium channel blockers for primary Raynaud's phenomenon: a meta-analysis. , 2005, Rheumatology.

[6]  P. Mehler Osteoporosis in anorexia nervosa: prevention and treatment. , 2003, The International journal of eating disorders.

[7]  M. Jacobson,et al.  The effect of estrogen-progestin treatment on bone mineral density in anorexia nervosa. , 2002, Journal of pediatric and adolescent gynecology.

[8]  E. Hachulla,et al.  [Digital necrosis in a patient with anorexia nervosa. Association of vasculopathy and radial artery injury]. , 2000, Presse medicale.

[9]  J. Lekakis,et al.  Effect of long-term estrogen therapy on brachial arterial endothelium-dependent vasodilation in women with Raynaud's phenomenon secondary to systemic sclerosis. , 1998, The American journal of cardiology.

[10]  J. Comas,et al.  Ischémie aiguë d'un membre supérieur révélatrice d'une maladie de Buerger. Rôle favorisant d'une anorexie mentale , 1992 .

[11]  J. Foreman,et al.  Anorexia Nervosa Associated with Acromegaloid Features, Onset of Acrocyanosis and Raynaud's Phenomenon and Worsening of Chilblains , 1990, Journal of the Royal Society of Medicine.

[12]  P. Jarrett Raynaud's disease and oral contraceptives. , 1976, British medical journal.

[13]  C. Badiu Harrison's Principles of Internal Medicine 16th ed , 2005 .

[14]  U. Kaur,et al.  Anorexia nervosa in a patient with systemic lupus erythematosus , 2004, Rheumatology International.

[15]  J. Belch,et al.  Raynaud's phenomenon. , 1997, Cardiovascular Research.

[16]  M. YebraBango,et al.  [Treatment of systemic lupus erythematosus]. , 1995, Revista clinica espanola.

[17]  Dc Washington Diagnostic and Statistical Manual of Mental Disorders, 4th Ed. , 1994 .

[18]  H. Julkunen Oral contraceptives in systemic lupus erythematosus: side-effects and influence on the activity of SLE. , 1991, Scandinavian journal of rheumatology.